Louis Chenevert is a successful Canadian businessman who was the Chairman and Chief Executive Officer of United Technologies Corporation (UTC) from 2006 to 2014, being with the company for nearly 20 years. He is a graduate of the prestigious Hautes Etudes Commerciales-Montreal, graduating in 1979. Prior to his time at UTC, Mr. Chenvert held the title of President at Canadian aircraft engine manufacturer Pratt and Whitney Corporation. Prior to his time at Pratt and Whiney, he spent 14 years at General Motors. With his vast amount of experience in the business world, Mr. Chenevert has established himself as a corporate giant.
Mr. Chenevert is a pragmatic leader who, during his time at UTC, help secure millions of dollars in government contracts from both Canada and the United States. This is one sector of the economy that has been very good to UTC over the years. With him at the helm UTC enjoyed an 8% return (profit) to shareholders on average. This made him a favorite among shareholders. In 2012, Chenevert oversaw the acquisition of Goodrich, an aircraft equipment company, for over $16 million. This was the largest acquisition in UTC’s history and is regarded as a deal that could pay huge dividends for the company in the years to come.
Louis took over UTC and nearly single-handedly turned the business into one of the most profitable conglomerates in the world. He turned UTC into a full-service manufacturer instead of just an aircraft engine manufacturer. He is responsible for steering the company’s engine business toward more fuel-saving designs, passing savings onto the consumer while boosting profits at the same time. His excellent record has made him become a household name in the aircraft industry. There is no doubt that Mr. Louis R. Chenevert is one of the greatest business giants of the last century.
Talk Fusion is a revolutionary video marketing and communications oriented company that has been in the business for the better part of the past decade. Talk Fusion was created by CEO Bob Reina as an answer to what he believed to be one of the most important and effective new growing markets: video advertising. Reina early on realized the power that video offered and so he made it his goal to create a platform and suite of marketing tools that directly took advantage of it. Now, in 2016, Bob Reina’s Talk Fusion is being handsomely rewarded for their work with a special industry award.
This past year saw Talk Fusion release what is potentially one of their most important pieces of software: the Talk Fusion Video Chat program. Video Chat is an application designed to connect users face to face, across platforms, in a live video chat. Built on WebRTC technology and available for both Android and iTunes, the Video Chat app has the potential to be a true game changer when things are all said and done. Fortunately for Talk Fusion, people took notice of its power right away. Talk Fusion was handed the 2016 Communication Solutions Product of the Year Award for their work on Video Chat. The award was presented by a company named Technology Marketing Corporation. This is actually the second award that Talk Fusion has taken home from TMC.
The TMC award for Communication Solutions is handed out to companies that do the best in paving the way for changes within the video marketing world. Rich Tehrani, CEO at the TMC, said this: True leaders within their industries, these honorees represent the best of the best products and solutions available on the market today.” Tehrani’s words were simple and powerful and a symbol of the hard work that Talk Fusion has been putting in.
The recent award will join the mantle where Talk Fusion has been collecting many others over the years. Talk Fusion is now focused on 2017 for another chance to make a statement in an industry that is all too ready to move on to the next big thing. Learn more: https://www.youtube.com/user/TalkFusionOfficial
Amicus Therapeutics is a worldwide biotechnology company dealing with innovative and advanced therapies to treat various deadly rare diseases. They have also developed treatments meant to combat human genetic disorders. The company’s current and lead product is the migalastat, a personalized medicine developed to treat patients with Fabry disease in accordance to their genetic diagnosis. Another late-stage developed product is the SD-101, a therapy for the Epidermolysis Bullosa (EB). EB is a sporadic but deadly genetic disorder of the connective tissue. Amicus Therapeutics is leveraging their Chaperone-Advanced Replacement Therapy (CHART) and biologics principle technologies to generate novel enzyme replacement therapy (ERT) products. The new products are for diseases such as Pompe disease, Fabry disease, and other Lysosomal Storage Disorders (LSDs).
The company’s lead biologics program so far is ATB200/AT2221, an ERT uniquely designed for Pompe disease which will be given in combination with a pharmacological chaperone. The ERT is developed by specifically targeting the mutated proteins, and this approach is devoted to gaining enhanced treatments for the rare genetic diseases. Amicus Therapeutics has the passion for science which motivates the company towards their success. They have different programs which include; Epidermolysis Bullosa program, Fabry Disease Program, Pompe Disease program and Preclinical Programs. At a recent Scientific Conference, the team presented their elementary clinical data concerning Pompe Disease. They also got to learn any latest research in the neuromuscular disease.
Amicus Therapeutics won an award in 2016 for their first drug acceptance and approval (YahooFinance). John Crowley, the chairman of the company, was the one who accepted the Innovator Award on behalf of the enterprise. Amicus also has an intern program that takes people from different parts of the world to learn and gain the experience across the various disciplines. The program helps many individuals and being global it is an efficient method to distribute their knowledge all over. Amicus Therapeutics also holds volunteer programs. They spent three days helping the Habitat for Humanity in Monmouth County; together with the communities, they developed better and affordable houses for people in the area. Amicus Therapeutics is a company which values the lives of individuals, and their fundamental goal is to make the world a better place.
More about Amicus Therapeutics at https://www.crunchbase.com/organization/amicus-therapeutics
In this age that we live in, innovation is very important. It’s the factor behind successful businesses such as Apple, Google, and Facebook. In this sector, Equities First Holdings has not been left behind. This is the reason why the company is involved in providing stock based loans as banks, and other financial institutions continue to tighten their lending criteria. Since the company was established in the year 2002 by Al Christy, it has committed to serving their clients diligently and with integrity. For those that have dealt with Equities First Holding, they can assure you that the company will return your stocks upon the end of the deal and what Equities First Holdings knows.
One of the major benefits of choosing Equities First Holdings as your service provider in finance is that they offer loans at low interests’ rate. Another benefit rather than low interests rates is that they are fixed. This is unlike bank loans that have rates that change from time to time. According to Equities First Holdings, a loan from them must not be used for the intended purpose. Instead, the loan can be diverted to other projects. This makes it suitable for long term and short term projects in business or personal improvement projects and more information click here.
For the last 14 years, the company can report that they have conducted transactions that have generated them over $1.6 billion. However, to achieve this feat, the company has had to diversify. This means that the company has branches in other cities and countries other than Indianapolis and United States respectively. In the US, Equities First Holdings has a subsidiary in New York. Worldwide subsidiaries can be found in Hong Kong, Australia, the United Kingdom and South Africa. Equities First Holdings Bangkok and Equities First Holdings Sydney are other subsidiaries of the company. In Australia, they have other offices in Melbourne and Perth and Equities First Holdings lacrosse camp.
More Visit: https://uk.linkedin.com/company/equities-first-holdings-llc